About Ceramide glucosyltransferase
Ceramide glucosyltransferase (UGCG) is a protein
from Homo sapiens identified by UniProt accession
Q16739, 394 residues long.
MolForge cross-references it against 0 known binders and
239 disease associations.
Target properties
| Protein name | Ceramide glucosyltransferase |
| UniProt accession | Q16739 |
| Gene | UGCG |
| Organism | Homo sapiens |
| Length | 394 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (3)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (239)
Diseases linked to this target (Open Targets).
- Gaucher disease · score 0.58
- Niemann-Pick disease type C · score 0.44
- Red cell distribution width · score 0.44
- mean corpuscular volume · score 0.39
- erythrocyte count · score 0.38
- Fabry disease · score 0.38
- neurodegenerative disease · score 0.37
- neutrophil count · score 0.36
- Gaucher disease type 1 · score 0.34
- Gaucher disease type 3 · score 0.33
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q16739-F1 | alphafold | PREDICTED | 93.19 | — |
Amino-acid sequence (394 residues)
MALLDLALEG MAVFGFVLFL VLWLMHFMAI IYTRLHLNKK ATDKQPYSKL PGVSLLKPLK GVDPNLINNL ETFFELDYPK YEVLLCVQDH DDPAIDVCKK LLGKYPNVDA RLFIGGKKVG INPKINNLMP GYEVAKYDLI WICDSGIRVI PDTLTDMVNQ MTEKVGLVHG LPYVADRQGF AATLEQVYFG TSHPRYYISA NVTGFKCVTG MSCLMRKDVL DQAGGLIAFA QYIAEDYFMA KAIADRGWRF AMSTQVAMQN SGSYSISQFQ SRMIRWTKLR INMLPATIIC EPISECFVAS LIIGWAAHHV FRWDIMVFFM CHCLAWFIFD YIQLRGVQGG TLCFSKLDYA VAWFIRESMT IYIFLSALWD PTISWRTGRY RLRCGGTAEE ILDV
Explore Ceramide glucosyltransferase with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets